Amber Specialty Pharmacy Added to Eisai’s LENVIMA® Network

Now dispensing LENVIMA® for various types of cancer.

OMAHA, Neb. (May 11, 2022) – Amber Specialty Pharmacy announces today that they will begin dispensing LENVIMA® (lenvatinib). Used by itself, LENVIMA® treats differentiated thyroid cancer (DTC) when it can no longer be treated with radioactive iodine, and hepatocellular carcinoma (HCC) when it cannot be removed by surgery. LENVIMA® is used with other medications to treat additional types of cancers, including advanced renal cell carcinoma (RCC), advanced endometrial carcinoma. LENVIMA® is manufactured by Eisai.

Amber Specialty Pharmacy’s high-touch service model will support patients, caregivers, and oncology specialists throughout the country. Their Oncology Center of Excellence provides an enhanced level of care throughout a patient’s treatment journey.

“Supporting patients who are navigating a cancer diagnosis is one of the most important things we do,” said Kristin Williams, president of Amber Specialty Pharmacy. “We are honored Eisai recognizes the value our whole-health approach offers oncology patients. From reducing or eliminating financial barriers, to one-on-one counseling with our registered dietitian – and everything in between – oncology professionals can trust Amber Specialty Pharmacy to make sure patients have the medicine and support they deserve.”

For more information about Amber Specialty Pharmacy oncology services, call (888) 370-1724. Download the oncology referral form here.

Share Article

Amber Specialty Pharmacy App on cell phone

Download our app.

Download the Amber Specialty Pharmacy Mobile App.

Apple Store Button Google Play Store Button
Contact Us